In vitro and in vivo activity of Melittin combined with imipenem and meropenem against carbapenem-resistant <i>A. baumannii</i>
MEL appears to be a promising therapeutic candidate against carbapenem-resistant <i>A. baumannii</i>, and its combination with carbapenems may enhance in vivo efficacy.
Authors
- Banu Kaşkatepe (ORCID: https://orcid.org/0000-0002-9722-4267)
- Şükran Öztürk (ORCID: https://orcid.org/0000-0003-2729-171X)
- Meryem Güvenir (ORCID: https://orcid.org/0000-0002-9702-9947)
- Demet Genç Karadenİz
Institutions
- Ankara University (TR)
- Zonguldak Bülent Ecevit University (TR)
- University of Cyprus (CY)
- Final International University (CY)
Publication Details
- Journal
- Future Microbiology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1080/17460913.2025.2572931
- Primary Topic
- Healthcare and Venom Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00